Ruben Vergara
Overview
Explore the profile of Ruben Vergara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bastante T, Martin-Moreiras J, Alvarez A, Carballo Garrido J, Andraka L, Gomez Jaume A, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
77(11):936-946.
PMID: 39332624
Introduction And Objectives: This article presents the 2023 activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC). Methods: All interventional cardiology laboratories in Spain were...
2.
De Gregorio M, Olivotto I, Migliorini A, Vergara R, Buonamici P, Marchionni N, et al.
JACC Case Rep
. 2021 Jul;
1(2):208-212.
PMID: 34316786
A 57-year-old man admitted with severe carbon monoxide (CO) poisoning suffered life-threatening pulmonary embolism (PE) after hyperbaric oxygen therapy, in the absence of other risk factors for thromboembolism, and was...
3.
Vergara R, Vignini E, Ciabatti M, Migliorini A, Valenti R, Antoniucci D
Cardiovasc Revasc Med
. 2020 Jul;
22:10-15.
PMID: 32605903
Objectives: We sought to determine whether, in a real word context of patients with Acute Myocardial Infarction (AMI), multivessel disease (MVD) and cardiogenic shock (CS), the successful treatment with primary...
4.
De Gregorio M, Marcucci R, Migliorini A, Gori A, Giusti B, Vergara R, et al.
J Am Heart Assoc
. 2020 Feb;
9(4):e014676.
PMID: 32067582
Background Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first-line antiplatelet treatment in acute coronary syndrome. We...
5.
Valenti R, Migliorini A, De Gregorio M, Martone R, Berteotti M, Bernardini A, et al.
Catheter Cardiovasc Interv
. 2019 Aug;
95(1):145-153.
PMID: 31430034
Objective: The aim of the study was to assess the prognostic impact of successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and completeness of revascularization in the elderly. Background:...
6.
Vergara R, Valenti R, Migliorini A, Ciabatti M, De Gregorio M, Taborchi G, et al.
J Invasive Cardiol
. 2018 Dec;
30(12):443-446.
PMID: 30504512
Introduction: It is not clear if differences exist about treating left main bifurcation (LMB) and non-left main bifurcation (non-LMB) lesions by means of percutaneous coronary intervention (PCI). Methods: We prospectively...
7.
Migliorini A, Valenti R, Vergara R, De Gregorio M, Gabrielli E, De Vito E, et al.
Catheter Cardiovasc Interv
. 2017 Jul;
90(1):72-77.
PMID: 28707445
Background: Few data exist about crushing of EES for distal ULMD. Methods: From the Florence ULMD Percutaneous Coronary Interevention Registry consecutive patients with distal ULMD treated with EES were included...
8.
Vergara R, Valenti R, Migliorini A, Cerisano G, Carrabba N, Giurlani L, et al.
Am J Cardiol
. 2016 Nov;
119(3):351-354.
PMID: 27884422
Poor data exist about predictors of long-term cardiac mortality in patients presenting acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) treated with primary percutaneous coronary intervention (p-PCI), and current...
9.
Migliorini A, Valenti R, Parodi G, Vergara R, Buonamici P, Cerisano G, et al.
JACC Cardiovasc Interv
. 2016 May;
9(10):1001-7.
PMID: 27198680
Objectives: This study determined angiographic and clinical outcomes after everolimus-eluting stent (EES)-supported percutaneous coronary intervention for unprotected left main disease (ULMD) and high SYNTAX (SYNergy between PCI with TAXus and...
10.
Vergara R, Valenti R, Migliorini A, Parodi G, Giurlani L, Marrani M, et al.
J Invasive Cardiol
. 2016 May;
28(12):E193-E197.
PMID: 27187985
Objectives: We sought to investigate the prognostic impact of rheolytic thrombectomy (RT) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). Background: Very few data exist on...